{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:10:11Z","timestamp":1793293811434,"version":"4.5.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00705-025-06235-3","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T12:53:55Z","timestamp":1738846435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Dengue: epidemiology, diagnosis methods, treatment options, and prevention strategies"],"prefix":"10.1007","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0622-0719","authenticated-orcid":false,"given":"Dimple","family":"Kothari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0467-4963","authenticated-orcid":false,"given":"Niralee","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6810-2511","authenticated-orcid":false,"given":"Ashok Kumar","family":"Bishoyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"6235_CR1","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/v15030636","volume":"15","author":"L Facchinelli","year":"2023","unstructured":"Facchinelli L, Badolo A, McCall PJ (2023) Biology and Behaviour of Aedes aegypti in the Human Environment: Opportunities for Vector Control of Arbovirus Transmission. Viruses 15:636. https:\/\/doi.org\/10.3390\/v15030636","journal-title":"Viruses"},{"key":"6235_CR2","doi-asserted-by":"publisher","unstructured":"Chala B, Hamde F (2021) Emerging and Re-emerging Vector-Borne Infectious Diseases and the Challenges for Control: A Review. Front Public Heal 9. https:\/\/doi.org\/10.3389\/fpubh.2021.715759","DOI":"10.3389\/fpubh.2021.715759"},{"key":"6235_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7861\/clinmed.2021-0791","volume":"22","author":"SA Kularatne","year":"2022","unstructured":"Kularatne SA, Dalugama C (2022) Dengue infection: Global importance, immunopathology and management. Clin Med (Northfield Il) 22:9\u201313. https:\/\/doi.org\/10.7861\/clinmed.2021-0791","journal-title":"Clin Med (Northfield Il)"},{"key":"6235_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ et al (2013) The global distribution and burden of dengue. Nature 496:504\u2013507. https:\/\/doi.org\/10.1038\/nature12060","journal-title":"Nature"},{"key":"6235_CR5","doi-asserted-by":"publisher","first-page":"e988","DOI":"10.1016\/S2214-109X(19)30249-9","volume":"7","author":"A Wilder-Smith","year":"2019","unstructured":"Wilder-Smith A, Rupali P (2019) Estimating the dengue burden in India. Lancet Glob Heal 7:e988\u2013e989","journal-title":"Lancet Glob Heal"},{"key":"6235_CR6","unstructured":"World Health Organization (2009). Dengue guidelines for diagnosis, treatment, prevention and control: new edition. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/44188"},{"key":"6235_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1139\/cjm-2020-0572","volume":"67","author":"SK Roy","year":"2021","unstructured":"Roy SK, Bhattacharjee S (2021) Dengue virus: Epidemiology, biology, and disease aetiology. Can J Microbiol 67:687\u2013702","journal-title":"Can J Microbiol"},{"key":"6235_CR8","unstructured":"(2024) Dengue and severe dengue. In: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue"},{"key":"6235_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.55","volume":"2","author":"MG Guzman","year":"2016","unstructured":"Guzman MG, Gubler DJ, Izquierdo A et al (2016) Dengue infection. Nat Publ Gr 2:1\u201326. https:\/\/doi.org\/10.1038\/nrdp.2016.55","journal-title":"Nat Publ Gr"},{"key":"6235_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s12275-022-1625-y","volume":"60","author":"J Park","year":"2022","unstructured":"Park J, Kim J, Jang YS (2022) Current status and perspectives on vaccine development against dengue virus infection. J Microbiol 60:247\u2013254","journal-title":"J Microbiol"},{"key":"6235_CR11","doi-asserted-by":"publisher","first-page":"19839","DOI":"10.3402\/iee.v3i0.19839","volume":"3","author":"A Tuiskunen B\u00e4ck","year":"2013","unstructured":"Tuiskunen B\u00e4ck A, Lundkvist \u00c5 (2013) Dengue viruses\u2013 an overview. Infect Ecol Epidemiol 3:19839. https:\/\/doi.org\/10.3402\/iee.v3i0.19839","journal-title":"Infect Ecol Epidemiol"},{"key":"6235_CR12","doi-asserted-by":"publisher","unstructured":"Yong YK, Wong WF, Vignesh R (2022) Dengue Infection - Recent Advances in Disease Pathogenesis in the Era of COVID-19. 13:1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2022.889196","DOI":"10.3389\/fimmu.2022.889196"},{"key":"6235_CR13","doi-asserted-by":"publisher","unstructured":"Getachew D, Tekie H, Gebre-Michael T et al (2015) Breeding Sites of Aedes aegypti: Potential Dengue Vectors in Dire Dawa, East Ethiopia. Interdiscip Perspect Infect Dis 2015:706276. https:\/\/doi.org\/10.1155\/2015\/706276","DOI":"10.1155\/2015\/706276"},{"key":"6235_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1080\/22221751.2021.1944789","volume":"10","author":"O O\u2019Connor","year":"2021","unstructured":"O\u2019Connor O, Ou TP, Aubry F et al (2021) Potential role of vector-mediated natural selection in dengue virus genotype\/lineage replacements in two epidemiologically contrasted settings. Emerg Microbes Infect 10:1346\u20131357. https:\/\/doi.org\/10.1080\/22221751.2021.1944789","journal-title":"Emerg Microbes Infect"},{"key":"6235_CR15","first-page":"2","volume":"9","author":"L Lum","year":"2014","unstructured":"Lum L, Ng CJ, Khoo EM (2014) Managing dengue fever in primary care: A practical approach. Malaysian Fam physician Off J Acad Fam Physicians Malaysia 9:2\u201310","journal-title":"Malaysian Fam physician Off J Acad Fam Physicians Malaysia"},{"key":"6235_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1093\/cid\/cit594","volume":"57","author":"PK Lam","year":"2013","unstructured":"Lam PK, Tam DTH, Diet TV et al (2013) Clinical characteristics of dengue shock syndrome in vietnamese children: A 10-year prospective study in a single hospital. Clin Infect Dis 57:1577\u20131586. https:\/\/doi.org\/10.1093\/cid\/cit594","journal-title":"Clin Infect Dis"},{"key":"6235_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cell.2015.07.005","volume":"162","author":"MS Diamond","year":"2015","unstructured":"Diamond MS, Pierson TC (2015) Molecular Insight into Dengue Virus Pathogenesis and Its Implications for Disease Control. Cell 162:488\u2013492. https:\/\/doi.org\/10.1016\/j.cell.2015.07.005","journal-title":"Cell"},{"key":"6235_CR18","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejogrb.2021.04.035","volume":"261","author":"V Mulik","year":"2021","unstructured":"Mulik V, Dad N, Buhmaid S (2021) Dengue in pregnancy: Review article. Eur J Obstet Gynecol Reprod Biol 261:205\u2013210. https:\/\/doi.org\/10.1016\/j.ejogrb.2021.04.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6235_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.342.6157.415","volume":"342","author":"D Normile","year":"2013","unstructured":"Normile D (2013) Surprising New Dengue Virus Throws a Spanner in Disease Control Efforts. Sci (80-) 342:415\u2013415. https:\/\/doi.org\/10.1126\/science.342.6157.415","journal-title":"Sci (80-)"},{"key":"6235_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.tim.2013.12.011","volume":"22","author":"JP Messina","year":"2014","unstructured":"Messina JP, Brady OJ, Scott TW et al (2014) Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol 22:138\u2013146. https:\/\/doi.org\/10.1016\/j.tim.2013.12.011","journal-title":"Trends Microbiol"},{"key":"6235_CR21","doi-asserted-by":"publisher","unstructured":"Urmi TJ, Mosharrafa R, Al, Hossain MJ et al (2023) Frequent outbreaks of dengue fever in South Asian countries\u2014A correspondence analyzing causative factors and ways to avert. Heal Sci Rep 6. https:\/\/doi.org\/10.1002\/hsr2.1598","DOI":"10.1002\/hsr2.1598"},{"key":"6235_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7006a1","volume":"70","author":"G Paz-Bailey","year":"2021","unstructured":"Paz-Bailey G, Adams L, Wong JM et al (2021) Dengue Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep 70:1\u201316. https:\/\/doi.org\/10.15585\/mmwr.rr7006a1","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"6235_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3201\/eid2103\/141662","volume":"21","author":"S Kutsuna","year":"2015","unstructured":"Kutsuna S, Kato Y, Moi ML et al (2015) Autochthonous Dengue Fever, Tokyo, Japan, 2014. Emerg Infect Dis 21:517\u2013520. https:\/\/doi.org\/10.3201\/eid2103\/141662","journal-title":"Emerg Infect Dis"},{"key":"6235_CR24","unstructured":"PAHO (2019) Epidemiological update: dengue. PAHO\/WHO, Washington. https:\/\/www.paho.org\/hq\/index.php?option=com_content_view=article_id=15360-9-august-2019-dengue-epidemiological-update_Itemid=42346_lang=en"},{"key":"6235_CR25","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S1473-3099(14)70834-5","volume":"14","author":"F Schaffner","year":"2014","unstructured":"Schaffner F, Mathis A (2014) Dengue and dengue vectors in the WHO European region: Past, present, and scenarios for the future. Lancet Infect Dis 14:1271\u20131280. https:\/\/doi.org\/10.1016\/S1473-3099(14)70834-5","journal-title":"Lancet Infect Dis"},{"key":"6235_CR26","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s40121-021-00470-2","volume":"10","author":"M Du","year":"2021","unstructured":"Du M, Jing W, Liu M, Liu J (2021) The Global Trends and Regional Differences in Incidence of Dengue Infection from 1990 to 2019: An Analysis from the Global Burden of Disease Study 2019. Infect Dis Ther 10:1625\u20131643. https:\/\/doi.org\/10.1007\/s40121-021-00470-2","journal-title":"Infect Dis Ther"},{"key":"6235_CR27","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/tropicalmed7080180","volume":"7","author":"N Tian","year":"2022","unstructured":"Tian N, Zheng J-X, Guo Z-Y et al (2022) Dengue Incidence Trends and Its Burden in Major Endemic Regions from 1990 to 2019. Trop Med Infect Dis 7:180. https:\/\/doi.org\/10.3390\/tropicalmed7080180","journal-title":"Trop Med Infect Dis"},{"key":"6235_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijid.2020.07.033","volume":"99","author":"MN Sahak","year":"2020","unstructured":"Sahak MN (2020) Dengue fever as an emerging disease in Afghanistan: Epidemiology of the first reported cases. Int J Infect Dis 99:23\u201327. https:\/\/doi.org\/10.1016\/j.ijid.2020.07.033","journal-title":"Int J Infect Dis"},{"key":"6235_CR29","doi-asserted-by":"publisher","first-page":"100712","DOI":"10.1016\/j.eclinm.2020.100712","volume":"32","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Zhan J, Chen L et al (2021) Global, regional, and national dengue burden from 1990 to 2017: A systematic analysis based on the global burden of disease study 2017. EClinicalMedicine 32:100712. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100712","journal-title":"EClinicalMedicine"},{"key":"6235_CR30","unstructured":"WHO (2023) Disease Outbreak News; Dengue\u2013 Global situation. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON498"},{"key":"6235_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/trstmh\/traa158","volume":"115","author":"T Tsheten","year":"2021","unstructured":"Tsheten T, Gray DJ, Clements ACA, Wangdi K (2021) Epidemiology and challenges of dengue surveillance in the WHO South-East Asia Region. Trans R Soc Trop Med Hyg 115:583\u2013599","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6235_CR32","unstructured":"WHO (2022) Dengue and severe dengue. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue"},{"key":"6235_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1099\/vir.0.060384-0","volume":"95","author":"ML Moi","year":"2014","unstructured":"Moi ML, Takasaki T, Omatsu T et al (2014) Demonstration of marmosets (Callithrix jacchus) as a non-human primate model for secondary dengue virus infection: high levels of viraemia and serotype cross-reactive antibody responses consistent with secondary infection of humans. J Gen Virol 95:591\u2013600. https:\/\/doi.org\/10.1099\/vir.0.060384-0","journal-title":"J Gen Virol"},{"key":"6235_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jmr.2352","volume":"27","author":"O Lisova","year":"2014","unstructured":"Lisova O, Belkadi L, Bedouelle H (2014) Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus. J Mol Recognit 27:205\u2013214. https:\/\/doi.org\/10.1002\/jmr.2352","journal-title":"J Mol Recognit"},{"key":"6235_CR35","doi-asserted-by":"publisher","unstructured":"Anantapreecha S, Chanama S, A-nuegoonpipat A, et al (2005) Serological and virological features of dengue fever and dengue haemorrhagic fever in Thailand from 1999 to 2002. Epidemiol Infect 133:503\u20137. https:\/\/doi.org\/10.1017\/s0950268804003541","DOI":"10.1017\/s0950268804003541"},{"key":"6235_CR36","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4269\/ajtmh.14-0628","volume":"92","author":"C-F Yung","year":"2015","unstructured":"Yung C-F, Lee K-S, Thein T-L et al (2015) Dengue Serotype-Specific Differences in Clinical Manifestation, Laboratory Parameters and Risk of Severe Disease in Adults, Singapore. Am Soc Trop Med Hyg 92:999\u20131005. https:\/\/doi.org\/10.4269\/ajtmh.14-0628","journal-title":"Am Soc Trop Med Hyg"},{"key":"6235_CR37","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1007\/s00705-013-1956-4","volume":"159","author":"E Suzarte","year":"2014","unstructured":"Suzarte E, Marcos E, Gil L et al (2014) Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus. Arch Virol 159:1629\u20131640. https:\/\/doi.org\/10.1007\/s00705-013-1956-4","journal-title":"Arch Virol"},{"key":"6235_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/v13020349","volume":"13","author":"M Torres","year":"2021","unstructured":"Torres M, Lima de Mendon\u00e7a M, Damasceno dos Santos Rodrigues C et al (2021) Dengue Virus Serotype 2 Intrahost Diversity in Patients with Different Clinical Outcomes. Viruses 13:349. https:\/\/doi.org\/10.3390\/v13020349","journal-title":"Viruses"},{"key":"6235_CR39","unstructured":"PAHO (2023) Epidemiological Update: Dengue, chikungunya and Zika. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON475"},{"key":"6235_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/ame2.12283","volume":"5","author":"X Yu","year":"2022","unstructured":"Yu X, Cheng G (2022) Contribution of phylogenetics to understanding the evolution and epidemiology of dengue virus. Anim Model Exp Med 5:410\u2013417. https:\/\/doi.org\/10.1002\/ame2.12283","journal-title":"Anim Model Exp Med"},{"key":"6235_CR41","doi-asserted-by":"publisher","first-page":"13496","DOI":"10.1038\/s41598-021-92783-y","volume":"11","author":"SP Yenamandra","year":"2021","unstructured":"Yenamandra SP, Koo C, Chiang S et al (2021) Evolution, heterogeneity and global dispersal of cosmopolitan genotype of Dengue virus type 2. Sci Rep 11:13496. https:\/\/doi.org\/10.1038\/s41598-021-92783-y","journal-title":"Sci Rep"},{"key":"6235_CR42","doi-asserted-by":"publisher","unstructured":"Naveca FG, Santiago GA, Maito RM et al (2023) Reemergence of Dengue Virus Serotype 3, Brazil, 2023. Emerg Infect Dis 29. https:\/\/doi.org\/10.3201\/eid2907.230595","DOI":"10.3201\/eid2907.230595"},{"key":"6235_CR43","doi-asserted-by":"publisher","first-page":"100378","DOI":"10.1016\/j.lanwpc.2021.100378","volume":"19","author":"H-Y Yuan","year":"2022","unstructured":"Yuan H-Y (2022) Preparing for and preventing dengue explosion in East Asia after border reopening. Lancet Reg Heal - West Pac 19:100378. https:\/\/doi.org\/10.1016\/j.lanwpc.2021.100378","journal-title":"Lancet Reg Heal - West Pac"},{"key":"6235_CR44","doi-asserted-by":"publisher","unstructured":"Jiang L, Ma D, Ye C et al (2018) Molecular Characterization of Dengue Virus Serotype 2 Cosmospolitan Genotype From 2015 Dengue Outbreak in Yunnan, China. Front Cell Infect Microbiol 8. https:\/\/doi.org\/10.3389\/fcimb.2018.00219","DOI":"10.3389\/fcimb.2018.00219"},{"key":"6235_CR45","doi-asserted-by":"publisher","first-page":"e59422","DOI":"10.1371\/journal.pone.0059422","volume":"8","author":"BP Drumond","year":"2013","unstructured":"Drumond BP, Mondini A, Schmidt DJ et al (2013) Circulation of Different Lineages of Dengue Virus 2, Genotype American\/Asian in Brazil: Dynamics and Molecular and Phylogenetic Characterization. PLoS ONE 8:e59422. https:\/\/doi.org\/10.1371\/journal.pone.0059422","journal-title":"PLoS ONE"},{"key":"6235_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12985-022-01773-7","volume":"19","author":"L Jiang","year":"2022","unstructured":"Jiang L, Liu Y, Su W et al (2022) Circulation of genotypes of dengue virus serotype 2 in Guangzhou over a period of 20 years. Virol J 19:47. https:\/\/doi.org\/10.1186\/s12985-022-01773-7","journal-title":"Virol J"},{"key":"6235_CR47","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-055522","author":"JM Wong","year":"2022","unstructured":"Wong JM, Adams LE, Durbin AP, Mu JL (2022) Dengue: A Growing Problem With New Interventions. 149. https:\/\/doi.org\/10.1542\/peds.2021-055522","journal-title":"149"},{"key":"6235_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.celrep.2020.108226.Antigenic","volume":"176","author":"C Eric","year":"2018","unstructured":"Eric C, Meyers BR, Solorzano J, James PD, Ganzer, Elaine S, Rennaker RL, Kilgard MP, Seth Hays (2018) \u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access. Physiol Behav 176:100\u2013106. https:\/\/doi.org\/10.1016\/j.celrep.2020.108226.Antigenic","journal-title":"Physiol Behav"},{"key":"6235_CR49","doi-asserted-by":"publisher","unstructured":"Wilder-Smith A (2018) Risk of dengue in travelers: Implications for dengue vaccination. Curr Infect Dis Rep 20(12):50. https:\/\/doi.org\/10.1007\/s11908-018-0656-3","DOI":"10.1007\/s11908-018-0656-3"},{"key":"6235_CR50","doi-asserted-by":"crossref","unstructured":"Travelers R, Shihada S, Emmerich P et al (2017) Genetic Diversity and New Lineages of. 23:2015\u20132018","DOI":"10.3201\/eid2302.160751"},{"key":"6235_CR51","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1016\/j.vaccine.2020.04.011","volume":"38","author":"M Girard","year":"2020","unstructured":"Girard M, Nelson CB, Picot V, Gubler DJ (2020) Arboviruses: A global public health threat. Vaccine 38:3989\u20133994. https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.011","journal-title":"Vaccine"},{"key":"6235_CR52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.4269\/ajtmh.19-0487","volume":"102","author":"HA Imad","year":"2020","unstructured":"Imad HA, Phumratanaprapin W, Phonrat B et al (2020) Cytokine Expression in Dengue Fever and Dengue Hemorrhagic Fever Patients with Bleeding and Severe Hepatitis. Am J Trop Med Hyg 102:943\u2013950. https:\/\/doi.org\/10.4269\/ajtmh.19-0487","journal-title":"Am J Trop Med Hyg"},{"key":"6235_CR53","doi-asserted-by":"publisher","first-page":"e3589","DOI":"10.7717\/peerj.3589","volume":"5","author":"K-M Soo","year":"2017","unstructured":"Soo K-M, Khalid B, Ching S-M et al (2017) Meta-analysis of biomarkers for severe dengue infections. PeerJ 5:e3589. https:\/\/doi.org\/10.7717\/peerj.3589","journal-title":"PeerJ"},{"key":"6235_CR54","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick LC, Gresh L, Halloran ME et al (2017) Antibody-dependent enhancement of severe dengue disease in humans. Sci (80-) 358:929\u2013932. https:\/\/doi.org\/10.1126\/science.aan6836","journal-title":"Sci (80-)"},{"key":"6235_CR55","doi-asserted-by":"publisher","unstructured":"Halstead SB (2014) Dengue Antibody-Dependent Enhancement: Knowns and Unknowns. https:\/\/doi.org\/10.1128\/microbiolspec.AID-0022-2014. Microbiol Spectr 2:","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"key":"6235_CR56","doi-asserted-by":"publisher","unstructured":"Conde JN, Silva EM, Barbosa AS, Mohana-Borges R (2017) The Complement System in Flavivirus Infections. Front Microbiol 8. https:\/\/doi.org\/10.3389\/fmicb.2017.00213","DOI":"10.3389\/fmicb.2017.00213"},{"key":"6235_CR57","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/v13071219","volume":"13","author":"R Kraivong","year":"2021","unstructured":"Kraivong R, Punyadee N, Liszewski MK et al (2021) Dengue and the Lectin Pathway of the Complement System. Viruses 13:1219. https:\/\/doi.org\/10.3390\/v13071219","journal-title":"Viruses"},{"key":"6235_CR58","doi-asserted-by":"publisher","unstructured":"Amorim MT, Naveca FG, Hern\u00e1ndez LHA et al (2024) Detection of a Multiple Circulation Event of Dengue Virus 2 Strains in the Northern Region of Brazil. Trop Med Infect Dis 9. https:\/\/doi.org\/10.3390\/tropicalmed9010017","DOI":"10.3390\/tropicalmed9010017"},{"key":"6235_CR59","doi-asserted-by":"publisher","unstructured":"Henriques P, Rosa A, Caldeira-Ara\u00fajo H et al (2023) Flying under the radar\u2013 impact and factors influencing asymptomatic DENV infections. Front Cell Infect Microbiol 13. https:\/\/doi.org\/10.3389\/fcimb.2023.1284651","DOI":"10.3389\/fcimb.2023.1284651"},{"key":"6235_CR60","doi-asserted-by":"publisher","first-page":"e0003522","DOI":"10.1371\/journal.pntd.0003522","volume":"9","author":"CAM van de Weg","year":"2015","unstructured":"van de Weg CAM, van den Ham H-J, Bijl MA et al (2015) Time since Onset of Disease and Individual Clinical Markers Associate with Transcriptional Changes in Uncomplicated Dengue. PLoS Negl Trop Dis 9:e0003522. https:\/\/doi.org\/10.1371\/journal.pntd.0003522","journal-title":"PLoS Negl Trop Dis"},{"key":"6235_CR61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.imj.2023.02.002","volume":"2","author":"JVN Josyula","year":"2023","unstructured":"Josyula JVN, Talari P, Pillai AKB, Mutheneni SR (2023) Analysis of gene expression profile for identification of novel gene signatures during dengue infection. Infect Med 2:19\u201330. https:\/\/doi.org\/10.1016\/j.imj.2023.02.002","journal-title":"Infect Med"},{"key":"6235_CR62","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.18632\/oncotarget.23784","volume":"9","author":"CD Palani","year":"2018","unstructured":"Palani CD, Ramanathapuram L, Lam-ubol A, Kurago ZB (2018) Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases \u00bd. Oncotarget 9:6814\u20136829. https:\/\/doi.org\/10.18632\/oncotarget.23784","journal-title":"Oncotarget"},{"key":"6235_CR63","doi-asserted-by":"publisher","first-page":"e0004731","DOI":"10.1371\/journal.pntd.0004731","volume":"10","author":"FR Strouts","year":"2016","unstructured":"Strouts FR, Popper SJ, Partidos CD et al (2016) Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates. PLoS Negl Trop Dis 10:e0004731. https:\/\/doi.org\/10.1371\/journal.pntd.0004731","journal-title":"PLoS Negl Trop Dis"},{"key":"6235_CR64","doi-asserted-by":"publisher","unstructured":"Almasy KM, Davies JP, Lisy SM et al (2021) Small-molecule endoplasmic reticulum proteostasis regulator acts as a broad-spectrum inhibitor of dengue and Zika virus infections. Proc Natl Acad Sci 118. https:\/\/doi.org\/10.1073\/pnas.2012209118","DOI":"10.1073\/pnas.2012209118"},{"key":"6235_CR65","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1016\/j.bmc.2019.07.038","volume":"27","author":"EF da Silva-J\u00fanior","year":"2019","unstructured":"da Silva-J\u00fanior EF, de Ara\u00fajo-J\u00fanior JX (2019) Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses. Bioorg Med Chem 27:3963\u20133978. https:\/\/doi.org\/10.1016\/j.bmc.2019.07.038","journal-title":"Bioorg Med Chem"},{"key":"6235_CR66","doi-asserted-by":"publisher","unstructured":"Norshidah H, Leow CH, Ezleen KE et al (2023) Assessing the potential of NS2B\/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach. Front Cell Infect Microbiol 13. https:\/\/doi.org\/10.3389\/fcimb.2023.1061937","DOI":"10.3389\/fcimb.2023.1061937"},{"key":"6235_CR67","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12985-015-0264-x","volume":"12","author":"H Wang","year":"2015","unstructured":"Wang H, Zhang D, Ge M et al (2015) Formononetin inhibits enterovirus 71 replication by regulating COX- 2\/PGE2 expression. Virol J 12:35. https:\/\/doi.org\/10.1186\/s12985-015-0264-x","journal-title":"Virol J"},{"key":"6235_CR68","doi-asserted-by":"publisher","first-page":"44701","DOI":"10.1038\/srep44701","volume":"7","author":"C-K Lin","year":"2017","unstructured":"Lin C-K, Tseng C-K, Wu Y-H et al (2017) Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents. Sci Rep 7:44701. https:\/\/doi.org\/10.1038\/srep44701","journal-title":"Sci Rep"},{"key":"6235_CR69","doi-asserted-by":"publisher","first-page":"e1006853","DOI":"10.1371\/journal.ppat.1006853","volume":"14","author":"N Chotiwan","year":"2018","unstructured":"Chotiwan N, Andre BG, Sanchez-Vargas I et al (2018) Dynamic remodeling of lipids coincides with dengue virus replication in the midgut of Aedes aegypti mosquitoes. PLOS Pathog 14:e1006853. https:\/\/doi.org\/10.1371\/journal.ppat.1006853","journal-title":"PLOS Pathog"},{"key":"6235_CR70","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3390\/v14020240","volume":"14","author":"LA St Clair","year":"2022","unstructured":"St Clair LA, Mills SA, Lian E et al (2022) Acyl-Coa Thioesterases: A Rheostat That Controls Activated Fatty Acids Modulates Dengue Virus Serotype 2 Replication. Viruses 14:240. https:\/\/doi.org\/10.3390\/v14020240","journal-title":"Viruses"},{"key":"6235_CR71","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1128\/CMR.00003-16","volume":"29","author":"MJ Broadhurst","year":"2016","unstructured":"Broadhurst MJ, Brooks TJG, Pollock NR (2016) Diagnosis of Ebola Virus Disease: Past, Present, and Future. Clin Microbiol Rev 29:773\u2013793. https:\/\/doi.org\/10.1128\/CMR.00003-16","journal-title":"Clin Microbiol Rev"},{"key":"6235_CR72","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1080\/17843286.2020.1837576","volume":"77","author":"K Wellekens","year":"2022","unstructured":"Wellekens K, Betrains A, De Munter P, Peetermans W (2022) Dengue: current state one year before WHO 2010\u20132020 goals. Acta Clin Belgica Int J Clin Lab Med 77:436\u2013444","journal-title":"Acta Clin Belgica Int J Clin Lab Med"},{"key":"6235_CR73","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1038\/nrmicro2459","volume":"8","author":"RW Peeling","year":"2010","unstructured":"Peeling RW, Artsob H, Pelegrino JL et al (2010) Evaluation of diagnostic tests: Dengue. Nat Rev Microbiol 8:S30\u2013S38. https:\/\/doi.org\/10.1038\/nrmicro2459","journal-title":"Nat Rev Microbiol"},{"key":"6235_CR74","doi-asserted-by":"crossref","unstructured":"Hunsperger EA, Mu\u00f1oz-Jord\u00e1n J, Beltran M et al (2016) Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm. Journal of Infectious Diseases. Oxford University Press, pp 836\u2013844","DOI":"10.1093\/infdis\/jiw103"},{"key":"6235_CR75","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4269\/ajtmh.12-0461","volume":"88","author":"TM Timiryasova","year":"2013","unstructured":"Timiryasova TM, Bonaparte MI, Luo P et al (2013) Optimization and Validation of a Plaque Reduction Neutralization Test for the Detection of Neutralizing Antibodies to Four Serotypes of Dengue Virus Used in Support of Dengue Vaccine Development. Am Soc Trop Med Hyg 88:962\u2013970. https:\/\/doi.org\/10.4269\/ajtmh.12-0461","journal-title":"Am Soc Trop Med Hyg"},{"key":"6235_CR76","doi-asserted-by":"publisher","first-page":"e94655","DOI":"10.1371\/journal.pone.0094655","volume":"9","author":"VGda Costa","year":"2014","unstructured":"Costa VGda, Marques-Silva AC, Moreli ML (2014) A Meta-Analysis of the Diagnostic Accuracy of Two Commercial NS1 Antigen ELISA Tests for Early Dengue Virus Detection. PLoS ONE 9:e94655. https:\/\/doi.org\/10.1371\/journal.pone.0094655","journal-title":"PLoS ONE"},{"key":"6235_CR77","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ijid.2014.02.002","volume":"26","author":"H Zhang","year":"2014","unstructured":"Zhang H, Li W, Wang J et al (2014) NS1-based tests with diagnostic utility for confirming dengue infection: a meta-analysis. Int J Infect Dis 26:57\u201366. https:\/\/doi.org\/10.1016\/j.ijid.2014.02.002","journal-title":"Int J Infect Dis"},{"key":"6235_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011155.pub2","author":"M Casenghi","year":"2018","unstructured":"Casenghi M, Kosack C, Li R et al (2018) NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD011155.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"6235_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jcv.2013.06.015","volume":"58","author":"FO Ferraz","year":"2013","unstructured":"Ferraz FO, Bomfim MRQ, Totola AH et al (2013) Evaluation of laboratory tests for dengue diagnosis in clinical specimens from consecutive patients with suspected dengue in Belo Horizonte, Brazil. J Clin Virol 58:41\u201346. https:\/\/doi.org\/10.1016\/j.jcv.2013.06.015","journal-title":"J Clin Virol"},{"key":"6235_CR80","unstructured":"(2024) Dengue. In: https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/dengue"},{"key":"6235_CR81","doi-asserted-by":"publisher","first-page":"e2116","DOI":"10.1371\/journal.pntd.0002116","volume":"7","author":"JJ Waggoner","year":"2013","unstructured":"Waggoner JJ, Abeynayake J, Sahoo MK et al (2013) Single-Reaction, Multiplex, Real-Time RT-PCR for the Detection, Quantitation, and Serotyping of Dengue Viruses. PLoS Negl Trop Dis 7:e2116. https:\/\/doi.org\/10.1371\/journal.pntd.0002116","journal-title":"PLoS Negl Trop Dis"},{"key":"6235_CR82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1743-422X-10-58","volume":"10","author":"P Patel","year":"2013","unstructured":"Patel P, Landt O, Kaiser M et al (2013) Development of one-step quantitative reverse transcription PCR for the rapid detection of flaviviruses. Virol J 10:58. https:\/\/doi.org\/10.1186\/1743-422X-10-58","journal-title":"Virol J"},{"key":"6235_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4248756","volume":"2017","author":"A Vina-Rodriguez","year":"2017","unstructured":"Vina-Rodriguez A, Sachse K, Ziegler U et al (2017) A Novel Pan- Flavivirus Detection and Identification Assay Based on RT-qPCR and Microarray. Biomed Res Int 2017:1\u201312. https:\/\/doi.org\/10.1155\/2017\/4248756","journal-title":"Biomed Res Int"},{"key":"6235_CR84","doi-asserted-by":"publisher","unstructured":"Xu B, Tewari P, Thein TL et al (2024) Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects. J Med Virol 96. https:\/\/doi.org\/10.1002\/jmv.29726","DOI":"10.1002\/jmv.29726"},{"key":"6235_CR85","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0140-6736(20)30414-1","volume":"395","author":"S Biswal","year":"2020","unstructured":"Biswal S, Borja-Tabora C, Martinez Vargas L et al (2020) Efficacy of a tetravalent dengue vaccine in healthy children aged 4\u201316 years: a randomised, placebo-controlled, phase 3 trial. Lancet 395:1423\u20131433. https:\/\/doi.org\/10.1016\/S0140-6736(20)30414-1","journal-title":"Lancet"},{"key":"6235_CR86","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/infdis\/jiw423","volume":"215","author":"JGH Low","year":"2017","unstructured":"Low JGH, Ooi EE, Vasudevan SG (2017) Current Status of Dengue Therapeutics Research and Development. J Infect Dis 215:S96\u2013S102. https:\/\/doi.org\/10.1093\/infdis\/jiw423","journal-title":"J Infect Dis"},{"key":"6235_CR87","first-page":"164","volume":"24","author":"MI Suliman","year":"2014","unstructured":"Suliman MI, Qayum I, Saeed F (2014) Randomized clinical trial of human interleukin-11 in Dengue fever-associated thrombocytopenia. J Coll Physicians Surg Pak 24:164\u2013168","journal-title":"J Coll Physicians Surg Pak"},{"key":"6235_CR88","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1159\/000354837","volume":"40","author":"MZK Assir","year":"2013","unstructured":"Assir MZK, Kamran U, Ahmad HI et al (2013) Effectiveness of Platelet Transfusion in Dengue Fever: A Randomized Controlled Trial. Transfus Med Hemotherapy 40:362\u2013368. https:\/\/doi.org\/10.1159\/000354837","journal-title":"Transfus Med Hemotherapy"},{"key":"6235_CR89","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.2217\/fmb.15.105","volume":"10","author":"CY Chan","year":"2015","unstructured":"Chan CY, Ooi EE (2015) Dengue: an update on treatment options. Future Microbiol 10:2017\u20132031. https:\/\/doi.org\/10.2217\/fmb.15.105","journal-title":"Future Microbiol"},{"key":"6235_CR90","doi-asserted-by":"publisher","first-page":"e0007420","DOI":"10.1371\/journal.pntd.0007420","volume":"13","author":"C Buhler","year":"2019","unstructured":"Buhler C, Winkler V, Runge-Ranzinger S et al (2019) Environmental methods for dengue vector control\u2013 A systematic review and meta-analysis. PLoS Negl Trop Dis 13:e0007420. https:\/\/doi.org\/10.1371\/journal.pntd.0007420","journal-title":"PLoS Negl Trop Dis"},{"key":"6235_CR91","doi-asserted-by":"publisher","unstructured":"Rather IA, Parray HA, Lone JB et al (2017) Prevention and Control Strategies to Counter Dengue Virus Infection. Front Cell Infect Microbiol 7. https:\/\/doi.org\/10.3389\/fcimb.2017.00336","DOI":"10.3389\/fcimb.2017.00336"},{"key":"6235_CR92","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.4314\/ahs.v21i3.21","volume":"21","author":"M Rohaizat Hassan","year":"2021","unstructured":"Rohaizat Hassan M, Atika Azit N, Mohd Fadzil S et al (2021) Insecticide resistance of Dengue vectors in South East Asia: a systematic review. Afr Health Sci 21:1124\u20131140. https:\/\/doi.org\/10.4314\/ahs.v21i3.21","journal-title":"Afr Health Sci"},{"key":"6235_CR93","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1073\/pnas.1715788115","volume":"115","author":"LB Carrington","year":"2018","unstructured":"Carrington LB, Tran BCN, Le NTH et al (2018) Field- and clinically derived estimates of Wolbachia -mediated blocking of dengue virus transmission potential in Aedes aegypti mosquitoes. Proc Natl Acad Sci 115:361\u2013366. https:\/\/doi.org\/10.1073\/pnas.1715788115","journal-title":"Proc Natl Acad Sci"},{"key":"6235_CR94","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.pt.2017.11.002","volume":"34","author":"I Dorigatti","year":"2018","unstructured":"Dorigatti I, McCormack C, Nedjati-Gilani G, Ferguson NM (2018) Using Wolbachia for Dengue Control: Insights from Modelling. Trends Parasitol 34:102\u2013113. https:\/\/doi.org\/10.1016\/j.pt.2017.11.002","journal-title":"Trends Parasitol"},{"key":"6235_CR95","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.actatropica.2013.09.023","volume":"132","author":"DO Carvalho","year":"2014","unstructured":"Carvalho DO, Costa-da-Silva AL, Lees RS, Capurro ML (2014) Two step male release strategy using transgenic mosquito lines to control transmission of vector-borne diseases. Acta Trop 132:S170\u2013S177. https:\/\/doi.org\/10.1016\/j.actatropica.2013.09.023","journal-title":"Acta Trop"},{"key":"6235_CR96","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13071-021-05132-3","volume":"15","author":"NA Ratcliffe","year":"2022","unstructured":"Ratcliffe NA, Furtado Pacheco JP, Dyson P et al (2022) Overview of paratransgenesis as a strategy to control pathogen transmission by insect vectors. Parasit Vectors 15:112. https:\/\/doi.org\/10.1186\/s13071-021-05132-3","journal-title":"Parasit Vectors"},{"key":"6235_CR97","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s13071-015-0959-2","volume":"8","author":"ABB Wilke","year":"2015","unstructured":"Wilke ABB, Marrelli MT (2015) Paratransgenesis: a promising new strategy for mosquito vector control. Parasit Vectors 8:342. https:\/\/doi.org\/10.1186\/s13071-015-0959-2","journal-title":"Parasit Vectors"},{"key":"6235_CR98","doi-asserted-by":"publisher","first-page":"e0207554","DOI":"10.1371\/journal.pone.0207554","volume":"13","author":"M Mascarenhas","year":"2018","unstructured":"Mascarenhas M, Garasia S, Berthiaume P et al (2018) A scoping review of published literature on chikungunya virus. PLoS ONE 13:e0207554. https:\/\/doi.org\/10.1371\/journal.pone.0207554","journal-title":"PLoS ONE"},{"key":"6235_CR99","doi-asserted-by":"publisher","first-page":"479","DOI":"10.20506\/rst.34.2.2373","volume":"34","author":"PF HORWOOD","year":"2015","unstructured":"Horwood PF, Buchy P (2015) Chikungunya. Rev Sci Tech l\u2019OIE 34:479\u2013489. https:\/\/doi.org\/10.20506\/rst.34.2.2373","journal-title":"Rev Sci Tech l\u2019OIE"},{"key":"6235_CR100","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12879-018-3006-z","volume":"18","author":"H Harapan","year":"2018","unstructured":"Harapan H, Rajamoorthy Y, Anwar S et al (2018) Knowledge, attitude, and practice regarding dengue virus infection among inhabitants of Aceh, Indonesia: a cross-sectional study. BMC Infect Dis 18:96. https:\/\/doi.org\/10.1186\/s12879-018-3006-z","journal-title":"BMC Infect Dis"},{"key":"6235_CR101","doi-asserted-by":"publisher","first-page":"taw043","DOI":"10.1093\/jtm\/taw043","volume":"23","author":"T Lalani","year":"2016","unstructured":"Lalani T, Yun H, Tribble D et al (2016) A comparison of compliance rates with anti-vectorial protective measures during travel to regions with dengue or chikungunya activity, and regions endemic for Plasmodium falciparum malaria. J Travel Med 23:taw043. https:\/\/doi.org\/10.1093\/jtm\/taw043","journal-title":"J Travel Med"},{"key":"6235_CR102","doi-asserted-by":"publisher","first-page":"e0003655","DOI":"10.1371\/journal.pntd.0003655","volume":"9","author":"NL Achee","year":"2015","unstructured":"Achee NL, Gould F, Perkins TA et al (2015) A Critical Assessment of Vector Control for Dengue Prevention. PLoS Negl Trop Dis 9:e0003655. https:\/\/doi.org\/10.1371\/journal.pntd.0003655","journal-title":"PLoS Negl Trop Dis"},{"key":"6235_CR103","doi-asserted-by":"publisher","unstructured":"Tripathi NK, Shrivastava A (2018) Recent Developments in Recombinant Protein\u2013Based Dengue Vaccines. Front Immunol 9. https:\/\/doi.org\/10.3389\/fimmu.2018.01919","DOI":"10.3389\/fimmu.2018.01919"},{"key":"6235_CR104","unstructured":"Sanofi Pasteur (2022) Dengvaxia (dengue tetravalent vaccine) prescribing information. Available at: https:\/\/www.fda.gov\/media\/124379\/download"},{"key":"6235_CR105","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.4269\/ajtmh.13-0304","volume":"89","author":"GH Dayan","year":"2013","unstructured":"Dayan GH, Garbes P, Noriega F et al (2013) Immunogenicity and Safety of a Recombinant Tetravalent Dengue Vaccine in Children and Adolescents Ages 9\u201316 Years in Brazil. Am J Trop Med Hyg 89:1058\u20131065. https:\/\/doi.org\/10.4269\/ajtmh.13-0304","journal-title":"Am J Trop Med Hyg"},{"key":"6235_CR106","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/INF.0b013e31829b8022","volume":"32","author":"L\u00c1 Villar","year":"2013","unstructured":"Villar L\u00c1, Rivera-Medina DM, Arredondo-Garc\u00eda JL et al (2013) Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9\u201316 Year Olds. Pediatr Infect Dis J 32:1102\u20131109. https:\/\/doi.org\/10.1097\/INF.0b013e31829b8022","journal-title":"Pediatr Infect Dis J"},{"key":"6235_CR107","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1016\/j.vaccine.2015.05.010","volume":"33","author":"LM Schwartz","year":"2015","unstructured":"Schwartz LM, Halloran ME, Durbin AP, Longini IM (2015) The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine 33:3293\u20133298. https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.010","journal-title":"Vaccine"},{"key":"6235_CR108","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/diseases12020032","volume":"12","author":"EC Okoye","year":"2024","unstructured":"Okoye EC, Mitra AK, Lomax T, Nunaley C (2024) Dengue Fever Epidemics and the Prospect of Vaccines: A Systematic Review and Meta-Analysis Using Clinical Trials in Children. Diseases 12:32. https:\/\/doi.org\/10.3390\/diseases12020032","journal-title":"Diseases"},{"key":"6235_CR109","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.vaccine.2019.11.061","volume":"38","author":"V Tricou","year":"2020","unstructured":"Tricou V, Low JG, Oh HM et al (2020) Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial. Vaccine 38:1513\u20131519. https:\/\/doi.org\/10.1016\/j.vaccine.2019.11.061","journal-title":"Vaccine"},{"key":"6235_CR110","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/infdis\/jiv179","volume":"212","author":"SL George","year":"2015","unstructured":"George SL, Wong MA, Dube TJT et al (2015) Safety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial. J Infect Dis 212:1032\u20131041. https:\/\/doi.org\/10.1093\/infdis\/jiv179","journal-title":"J Infect Dis"},{"key":"6235_CR111","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S1473-3099(14)70811-4","volume":"14","author":"JE Osorio","year":"2014","unstructured":"Osorio JE, Velez ID, Thomson C et al (2014) Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study. Lancet Infect Dis 14:830\u2013838. https:\/\/doi.org\/10.1016\/S1473-3099(14)70811-4","journal-title":"Lancet Infect Dis"},{"key":"6235_CR112","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/14760584.2017.1335201","volume":"16","author":"B Guy","year":"2017","unstructured":"Guy B, Noriega F, Ochiai RL et al (2017) A recombinant live attenuated tetravalent vaccine for the prevention of dengue. Expert Rev Vaccines 16:671\u2013684. https:\/\/doi.org\/10.1080\/14760584.2017.1335201","journal-title":"Expert Rev Vaccines"},{"key":"6235_CR113","unstructured":"WHO Dengue vaccine WHO position paper, September 2018\u2013 Recommendations. Vaccine"},{"key":"6235_CR114","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.coviro.2020.09.005","volume":"43","author":"AP Durbin","year":"2020","unstructured":"Durbin AP (2020) Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003\/TV005. Curr Opin Virol 43:79\u201387. https:\/\/doi.org\/10.1016\/j.coviro.2020.09.005","journal-title":"Curr Opin Virol"},{"key":"6235_CR115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cid\/ciab864","volume":"75","author":"L Rivera","year":"2022","unstructured":"Rivera L, Biswal S, S\u00e1ez-Llorens X et al (2022) Three-year Efficacy and Safety of Takeda\u2019s Dengue Vaccine Candidate (TAK-003). Clin Infect Dis 75:107\u2013117. https:\/\/doi.org\/10.1093\/cid\/ciab864","journal-title":"Clin Infect Dis"},{"key":"6235_CR116","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/infdis\/jis936","volume":"207","author":"AP Durbin","year":"2013","unstructured":"Durbin AP, Kirkpatrick BD, Pierce KK et al (2013) A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial. J Infect Dis 207:957\u2013965. https:\/\/doi.org\/10.1093\/infdis\/jis936","journal-title":"J Infect Dis"},{"key":"6235_CR117","doi-asserted-by":"publisher","unstructured":"Zeyaullah M, Muzammil K, AlShahrani AM et al (2022) Preparedness for the Dengue Epidemic: Vaccine as a Viable Approach. Vaccines 10:1940. https:\/\/doi.org\/10.3390\/vaccines10111940","DOI":"10.3390\/vaccines10111940"},{"key":"6235_CR118","doi-asserted-by":"publisher","unstructured":"Alves AMB, Costa SM, Pinto PBA (2021) Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge? Front Med Technol 3. https:\/\/doi.org\/10.3389\/fmedt.2021.640964","DOI":"10.3389\/fmedt.2021.640964"},{"key":"6235_CR119","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/20477724.2018.1514136","volume":"112","author":"S Bos","year":"2018","unstructured":"Bos S, Gadea G, Despres P (2018) Dengue: a growing threat requiring vaccine development for disease prevention. Pathog Glob Health 112:294\u2013305. https:\/\/doi.org\/10.1080\/20477724.2018.1514136","journal-title":"Pathog Glob Health"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-025-06235-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-025-06235-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T08:34:26Z","timestamp":1741336466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-025-06235-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":119,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6235"],"URL":"https:\/\/doi.org\/10.1007\/s00705-025-06235-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"10 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"48"}}